… There is a considerable variance across randomized controlled trials with regards to the
magnitude of improvement in exercise capacity among patients with coronary artery disease (…

… disease and kidney disease outcomes comparing the placebo groups in the secondary
prevention cohort versus the primary prevention … disease course. Subgroup analyses within each …

… 2 guidelines in the field of coronary artery disease (CAD): (1) a … secondary prevention for
myocardial infarction, and (2) guideline for revascularization of stable CAD by coronary artery …

… Exercise-based cardiac rehabilitation is integral to secondary prevention in patients with
coronary artery disease. Recently, the effectiveness and “superiority” of high-intensity interval …

Coronary artery disease (CAD) is presently the leading cause of death in the United States (US),
as it has been since 1990 (Fig. 1). 1 The quantity of years of life lost due a Department …

… disease has a multifactorial aetiology and can be prevented from developing in populations
primordially, and in individuals at high risk by primary prevention. … heart disease prevention …

… Cryptogenic stroke, defined as brain infarction that is not attributed to definite large vessel
atherosclerosis, small artery disease, or embolism from cardiac abnormalities despite …

… no diagnosis of peripheral arterial disease were considered as a primary prevention cohort.
… were not RCTs, investigated aspirin in secondary prevention of CVD, or were identified as …

… For individuals without known ASCVD, defined as CAD, peripheral artery disease, and/or
cerebral atherosclerosis, we applied the ACC/AHA Pooled Cohort Equations (PCE) to …

… The ceramide-phospholipid risk score showed comparable and synergistic predictive
performance with previously published CVD risk models for secondary prevention. …